12,564 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 12,564 shares of the medical instruments supplier’s stock, valued at approximately $255,000.

Several other large investors also recently bought and sold shares of the business. State of Alaska Department of Revenue increased its holdings in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after buying an additional 560 shares in the last quarter. UMB Bank n.a. increased its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares in the last quarter. MML Investors Services LLC increased its holdings in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after buying an additional 620 shares in the last quarter. Blue Trust Inc. increased its holdings in DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after buying an additional 707 shares in the last quarter. Finally, Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA in the 3rd quarter worth about $27,000. 95.70% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Trading Down 2.5 %

Shares of XRAY stock opened at $15.59 on Wednesday. DENTSPLY SIRONA Inc. has a 52-week low of $15.47 and a 52-week high of $34.28. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.53, a PEG ratio of 1.80 and a beta of 0.96. The stock has a fifty day simple moving average of $18.77 and a two-hundred day simple moving average of $21.39.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. DENTSPLY SIRONA’s payout ratio is presently -14.07%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on XRAY. Barrington Research cut their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. UBS Group cut their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Finally, Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.